Posts Tagged ‘Ron Rossbach’

Real-Time Adaptive Scheduling in Life Science Manufacturing

Posted in Life Sciences & Medical, Operations & Business Management on Tuesday, March 10th, 2020. No comments yet
Tags: , , ,

At the Biomanufacturing World Summit, Emerson’s Ron Rossbach presented on using digitalization and data integration to help drive operational efficiency. A key enabling technology for these performance gains is in real-time adaptive scheduling. This technology combines finite scheduling with dynamic updates from existing shop-floor execution systems to optimize operations. In 2018 Emerson acquired BioG, the leading provider of adaptive scheduling software, which is now being adopted across the industry.

Advancing Digital Plant Maturity for Biopharmaceutical Manufacturers

Posted in Life Sciences & Medical on Thursday, March 28th, 2019. No comments yet
Tags: , , ,

At the recent 2019 China International Biopharma4.0 Summit, Emerson’s Ron Rossbach presented Biopharma 4.0—Integrated Software Enabling Digital Capabilities. I’ll highlight some of Ron’s key points. He opened describing some of the main challenges biopharmaceutical manufacturers seek to address through enterprise digitalization—reducing time to market, increasing capital expenditure (CAPEX) productivity, increasing operational efficiency and improving forecasting […]

Fostering Organizational Collaboration in the Life Sciences

Posted in Industrial IoT, Life Sciences & Medical on Friday, January 11th, 2019. No comments yet
Tags: , ,

As automation technologies continue to incorporate commercial off the shelf technologies and cybersecurity concerns grow, the need for manufacturers’ Information Technology (IT), Operational Technology (OT) and Quality teams to collaborate grows. In a PharmTech article, Improving Production: How IT, OT, and Quality Can Collaborate, Emerson’s Will Goetz and Ron Rossbach describe how the different groups […]

Advancing Innovation in Pharmaceutical and Biologics Manufacturing

Posted in Life Sciences & Medical on Monday, August 13th, 2018. No comments yet
Tags: , , , , , ,

In a U.S. Food and Drug Administration’s FDA Voice blog post, FDA Budget Matters: Investing in Advanced Domestic Manufacturing, FDA Commissioner Dr. Scott Gottlieb opened noting: Advanced manufacturing, which includes various technologies, such as continuous manufacturing and 3D printing, holds great promise for improving the American market for drugs and biologicals. Emerson’s Ron Rossbach shared […]